Skip to content

Optimization of Ventilator Setting for Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Optimization of Ventilator Setting by Flow and Pressure Curves Analysis During Noninvasive Ventilation for Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01291303
Acronym
NIMV01AECB
Enrollment
70
Registered
2011-02-08
Start date
2009-10-31
Completion date
2010-10-31
Last updated
2011-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Exacerbation of Chronic Obstructive Airways Disease

Keywords

Non invasive ventilation, acute exacerbation of COPD, optimized ventilation

Brief summary

The analysis of flow and pressure curves generated by ventilators can be useful in the individuation of patient-ventilator asynchrony, notably in COPD patients. To date, however, a real clinical benefit of this approach to optimize ventilator setting has not been proven. The aim of the present study was to compare: optimized ventilation, driven by the analysis of flow and pressure curves, and standard setting (same initial setting, same time at the bedside, same physician, while the ventilator screen was obscured with numerical data always available). The primary aim was the normalization of pH at two hours, whilst secondary aims were change in PaCO2, respiratory rate, patient's tolerance to ventilation (all parameter evaluated at baseline, 30, 120, 360 minutes and 24 hours after the beginning of ventilation). 70 patients (26 females, aged 78±9 years, PaCO2 74±15 mmHg, pH 7.28±0.05, mean±SD) have been enrolled, with no basal difference between the two groups.

Interventions

PROCEDUREOptimized ventilation

Patients, ventilated in pressure support mode, were ventilated with initial setting PEEP and pressure support of 4 and as maximum tolerated cmH2O, inspiratory and expiratory trigger of 5 L/min and 50% of peak inspiratory flow, with changes driven by the analysis of flow and pressure curves; with a FiO2 to reach a SpO2 level between 88 and 92%.

Patients, ventilated in pressure support mode, were ventilated with standard setting of ventilation: -same initial setting, same time at the bedside (15 minutes at the beginning of NIV, and 5 minutes at each patients' new evaluation) same physician that optimized ventilation mode, while the ventilator screen was obscured (numerical data were, however, always available).

Sponsors

Ospedale Campo di Marte, UO Pneumologia e UTSIR, Lucca, IT
CollaboratorUNKNOWN
Valduce Hospital
CollaboratorOTHER
IRCCS Azienda Ospedaliero-Universitaria di Bologna
CollaboratorOTHER
Ente Ospedaliero Cantonale, Bellinzona
CollaboratorOTHER
Azienda Ospedaliera San Gerardo di Monza
CollaboratorOTHER
University of Milan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Consecutive patients aged \> 40 years affected by COPD exacerbation (defined as an acute change in a patient's baseline dyspnoea, cough and/or sputum beyond day-to-day variability sufficient to warrant a change in therapy), and respiratory acidosis (pH \< 7.35) that were treated by NIV in addition to standard medical therapy

Exclusion criteria

* The needing of intubation * The lack of informed consent

Design outcomes

Primary

MeasureTime frameDescription
arterial pH2 hoursThe primary outcome was the normalization of arterial pH (=pH≥7.35) at 2 hours from the beginning of non invasive ventilation

Secondary

MeasureTime frameDescription
carbon dioxide tension in arterial blood (PaCO2)120, 360 minutes and 24 hourscarbon dioxide tension (mmHg) in arterial blood measured 12O, 360 minutes and 24 hours after beginning of non invasive ventilation
respiratory rate (RR)120, 360 minutes and 24 hours after the beginning of ventilationrespiratory rate (RR) measured 120, 360 minutes and 24 hours after the beginning of non invasive ventilation
patient's tolerance to ventilation30, 120, 360 minutes and 24 hours after the beginning of ventilationThe patients tolerance to ventilation was evaluated on a visual analogue scale. This scale has been used and validated in previous studies and has five scores: 1) bad; 2) poor; 3) sufficient; 4) good; and 5) very good.
mortality30 days30-day mortality after beginning of non invasive ventilation

Countries

Italy, Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 27, 2026